(Q40146304)

17 September 2017

1 reference

title

Calcium antagonists. Clinical use in the treatment of arrhythmias (English)

1 reference

17 September 2017

B N Singh

1

1 reference

17 September 2017

K Nademanee

series ordinal

2

1 reference

17 September 2017

S H Baky

series ordinal

3

1 reference

17 September 2017

1 February 1983

1 reference

17 September 2017

1 reference

17 September 2017

25

1 reference

17 September 2017

125-153

1 reference

17 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198325020-00003

17 September 2017

0 references

cites work

Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog.

1 reference

12 December 2020

Drugs and the heart. III. Calcium antagonists

1 reference

12 December 2020

[The electrophysiological effects of the Ca-antagonists gallopamil (D 600), dimeditiapramine (Ro 11-1781) and verapamil in man (author's transl)]

1 reference

12 December 2020

Asystole after verapamil

1 reference

12 December 2020

Verapamil. A new class of antiarrhythmic agents with a variety of beneficial cardiovascular effects

1 reference

12 December 2020

Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction

1 reference

12 December 2020

Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome

1 reference

12 December 2020

The effects of anti-anginal drugs on AV-conduction in normal subjects.

1 reference

12 December 2020

Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil

1 reference

12 December 2020

Accurate rapid compact analog method for the quantification of frequency and duration of myocardial ischemia by semiautomated analysis of 24-hour Holter ECG recordings

1 reference

12 December 2020

Basic Mechanisms of ‘Calcium Antagonists’ (Slow Channel Blockers)

1 reference

12 December 2020

The Beneficial Effects of Verapamil in Chronic Atrial Fibrillation

1 reference

12 December 2020

Verapamil in cardiac arrhythmias.

1 reference

12 December 2020

The effect of a new calcium antagonist (Ro 11-1781) on the cardiac conduction system in man

1 reference

12 December 2020

Therapeutic implications of slow-channel blockade in cardiocirculatory disorders

1 reference

12 December 2020

Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study

1 reference

12 December 2020

Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia

1 reference

12 December 2020

Verapamil-induced ventricular regularity in atrial fibrillation. Effects of exercise, isoproterenol, atropine and conversion to sinus rhythm

1 reference

12 December 2020

Verapamil in Prophylaxis of Paroxysmal Atrioventricular Nodal Reentrant Tachycardia

1 reference

12 December 2020

Verapamil in cardiology

1 reference

12 December 2020

Immediate effects of intravenous verapamil on atrial fibrillation

1 reference

12 December 2020

Verapamil for PSVT in patients with WPW

1 reference

12 December 2020

Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome

1 reference

12 December 2020

Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation

1 reference

12 December 2020

Future relationships of hospitals in population medicine

1 reference

12 December 2020

Calcium antagonists and cardiac dysrhythmias

1 reference

12 December 2020

[Treatment of cardiac arrhythmias with Verapamil (author's transl)]

1 reference

12 December 2020

Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies

1 reference

12 December 2020

Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review

1 reference

12 December 2020

Clinical pharmacology of slow channel blocking agents

1 reference

12 December 2020

Demonstration of Dual A-V Nodal Pathways in Patients with Paroxysmal Supraventricular Tachycardia

1 reference

12 December 2020

Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs

1 reference

12 December 2020

Comparison of verapamil and practolol in paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias

1 reference

12 December 2020

Calcium antagonists: mechanisms of action in arrhythmias

1 reference

12 December 2020

Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations

1 reference

12 December 2020

Electrophysiologic properties and response to pharmacologic agents of fibers from diseased human atria

1 reference

12 December 2020

Fluorometric Assay of Verapamil in Biological Fluids and Tissues

1 reference

12 December 2020

Electrophysiologic evaluation of intravenous verapamil in man

1 reference

12 December 2020

Effects of verapamil on ventricular rhythm during acute coronary occlusion.

1 reference

12 December 2020

Electrophysiology and Antiarrhythmic Effects of Calcium Antagonists

1 reference

12 December 2020

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

1 reference

12 December 2020

Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia

1 reference

12 December 2020

Effects of verapamil in ventricular premature beats of acute myocardial infarction

1 reference

12 December 2020

Digitalis and atrial tachycardia with block

1 reference

12 December 2020

1 reference

12 December 2020

Clinical uses of calcium ion antagonists in arrhythmias

1 reference

12 December 2020

Role of calcium antagonists in cardiovascular therapy

1 reference

12 December 2020

Effect of verapamil in infants with paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study

1 reference

12 December 2020

Demonstration of a dual A-V nodal conduction system in the isolated rabbit heart

1 reference

12 December 2020

Arrhythmias in infants and children

1 reference

12 December 2020

Effects of Verapamil on Accessory Pathway Properties and Induction of Circus Movement Tachycardia in Patients with the Wolff-Parkinson-White Syndrome

1 reference

12 December 2020

Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease

1 reference

12 December 2020

Safety and efficacy of short- and long-term verapamil therapy in children with tachycardia

1 reference

12 December 2020

Pharmacological basis for the therapeutic applications of slow-channel blocking drugs

1 reference

12 December 2020

Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias

1 reference

12 December 2020

Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and children

1 reference

12 December 2020

Comparative efficiency of quinidine and verapamil in the maintenance of sinus rhythm after DC conversion of atrial fibrillation. A controlled clinical trial

1 reference

12 December 2020

Oral verapamil as maintenance therapy after cardioversion for atrial fibrillation

1 reference

12 December 2020

Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome

1 reference

12 December 2020

Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis

1 reference

12 December 2020

Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Verapamil in cardiac dysrhythmias during anaesthesia

1 reference

12 December 2020

Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy

1 reference

12 December 2020

Effects of verapamil on supraventricular tachycardia in children

1 reference

12 December 2020

Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular nodal tachycardia

1 reference

12 December 2020

Verapamil in the treatment of paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Verapamil protein binding in patients and in normal subjects

1 reference

12 December 2020

Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

Verapamil in cardiac arrhythmias

1 reference

12 December 2020

The influence of verapamil on serum digoxin concentration

1 reference

12 December 2020

Calcium antagonists: long-awaited new therapy for heart disease

1 reference

12 December 2020

Effect on paroxysmal re-entrant supraventricular tachycardia of a drug affecting calcium transport (Ro 11-1781)

1 reference

12 December 2020

New perspectives in the pharmacologic therapy of cardiac arrhythmias

1 reference

12 December 2020

Electrophysiologic effects of diltiazem, a calcium antagonist, in patients with impaired sinus or atrioventricular node function

1 reference

12 December 2020

Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial

1 reference

12 December 2020

Influence of various antiarrhythmic drugs (Aprindine, ajmaline, verapamil, oxprenolol, orciprenaline) on functional properties of accessory A-V pathways

1 reference

12 December 2020

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

12 December 2020

Gas chromatographic determination of verapamil in plasma and urine

1 reference

12 December 2020

Treatment of supraventricular arrhythmias with intravenous and oral verapamil

1 reference

12 December 2020

Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action

1 reference

12 December 2020

Cellular mechanisms for cardiac arrhythmias

1 reference

12 December 2020

Verapamil in the Treatment of Atrial Tachycardia with Block

1 reference

12 December 2020

Hemodynamic effects of verapamil and practolol in man

1 reference

12 December 2020

Prevention of ventricular fibrillation induced by coronary ligation

1 reference

12 December 2020

Treatment of Arrhythmias by Blocking Slow Current

1 reference

12 December 2020

Digoxin plasma concentrations and nifedipine

1 reference

12 December 2020

Verapamil versus placebo in atrial fibrillation and atrial flutter

1 reference

12 December 2020

Verapamil: a review of its pharmacological properties and therapeutic use.

1 reference

12 December 2020

Human electropharmacology of the calcium antagonist dimeditiapramine (Ro 11-1781) in coronary patients

1 reference

12 December 2020

Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris

1 reference

12 December 2020

Reduced verapamil clearance during long-term oral administration

1 reference

12 December 2020

Action of verapamil on sinus node, atrioventricular, and intraventricular conduction

1 reference

12 December 2020

Verapamil in life-threatening tachyarrhythmias

1 reference

12 December 2020

Verapamil in atrial fibrillation and atrial flutter

1 reference

12 December 2020

Verapamil in the treatment of PSVT.

1 reference

12 December 2020

10.2165/00003495-198325020-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference